ArkBio
Developer of innovative therapeutics created to address unmet medical needs in the area of respiratory viral infection a
Drug Discovery
📍 Shanghai, China
Founded 2013
Current Valuation
$604M
as of 2021-Q1
PRIVATE
Developer of innovative therapeutics created to address unmet medical needs in the area of respiratory viral infection and viral hepatitis.
Company Profile
Last Round
Series C1 — $86M (Jan 2021)
Fundraising Status
Series C1 · $86M · 5y 5mo ago
privateTotal raised $211M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C1 | $86M | Jan 2021 | — | $604M |
MedicalBiotechnology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q1. Refreshed quarterly.